Lyra Therapeutics Inc

NASDAQ:LYRA  
5.80
+0.19 (+3.39%)
Earnings Announcements

Lyra Therapeutics Reports First Quarter 2022 Financial Results And Provides Corporate Update

Published: 05/10/2022 11:21 GMT
Lyra Therapeutics Inc (LYRA) - Lyra Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Lyra Therapeutics Inc - Expects Its Cash Balance to Be Sufficient to Fund Its Planned Operations Through Mid-2024.
Lyra Therapeutics Inc - Qtrly Net Loss per Share $0.54.
Revenue is expected to be $1.91 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $1.69 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.